Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Z. N. Nersesyan"'
Publikováno v:
Терапевтический архив, Vol 87, Iss 8, Pp 44-50 (2015)
Aim. To provide a rationale for the clinical efficacy and safety of prolonged-release indapamide used in the combination therapy of patients with chronic obstructive pulmonary disease concurrent (COPD) concurrent with hypertension. Subjects and metho
Externí odkaz:
https://doaj.org/article/45404eb0652947db9076663603cc60bb
Publikováno v:
Системные гипертензии, Vol 11, Iss 2, Pp 54-58 (2014)
There is a problem of medicamental correction of arterial hypertension (AH) in patients with chronic obstructive lung disease (COLD), because number of drugs for the treatment of AH is limited in patients with bronchoobstractive diseases.The study sh
Externí odkaz:
https://doaj.org/article/2ee4fd92c6644f579bf5577f3865ed6c
Publikováno v:
Russian Pulmonology. 30:278-284
One of the main pathogenetic mechanisms combining chronic obstructive pulmonary disease (COPD) and arterial hypertension (AH) is a persistence systemic inflammation leading to the formation of endothelial dysfunction (ED), which serves as an independ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c006f93cf2914d66bf8bbdfb857a035f
https://doi.org/10.18093/0869-0189-2020-30-3-278-284
https://doi.org/10.18093/0869-0189-2020-30-3-278-284
Publikováno v:
Russian Pulmonology. 25:561-565
This study was aimed at determination relationships between systemic inflammation and endothelial dysfunction biomarkers and different cardiovascular and respiratory parameters in patients with chronic obstructive pulmonary disease (COPD) and comorbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c366bf8e5885e9136ebb74651b87b065
https://doi.org/10.18093/0869-0189-2015-25-5-561-565
https://doi.org/10.18093/0869-0189-2015-25-5-561-565
Publikováno v:
Системные гипертензии, Vol 11, Iss 2, Pp 54-58 (2014)
There is a problem of medicamental correction of arterial hypertension (AH) in patients with chronic obstructive lung disease (COLD), because number of drugs for the treatment of AH is limited in patients with bronchoobstractive diseases.The study sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6675c7e25277de76ffa63f83faca46c2
https://doi.org/10.26442/sg29026
https://doi.org/10.26442/sg29026
Publikováno v:
Терапевтический архив, Vol 87, Iss 8, Pp 44-50 (2015)
To provide a rationale for the clinical efficacy and safety of prolonged-release indapamide used in the combination therapy of patients with chronic obstructive pulmonary disease concurrent (COPD) concurrent with hypertension.Sixty-five patients (50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ca942e28081a97666d8c15777a809f
https://pubmed.ncbi.nlm.nih.gov/26824815
https://pubmed.ncbi.nlm.nih.gov/26824815
Publikováno v:
1.12 Clinical Problems - COPD.
Endothelial dysfunction is a common pathogenetic mechanism of COPD and hypertension. Identification of additional pleiotropic effects of antihypertensive drugs is very actual. Aims: To identify opportunities for correction of endothelial dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d160d7a019b4cf730effb64862daac69
https://doi.org/10.1183/13993003.congress-2015.pa409
https://doi.org/10.1183/13993003.congress-2015.pa409